0001683168-21-000713.txt : 20210225 0001683168-21-000713.hdr.sgml : 20210225 20210225120346 ACCESSION NUMBER: 0001683168-21-000713 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210225 DATE AS OF CHANGE: 20210225 EFFECTIVENESS DATE: 20210225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VININGS HOLDINGS, INC. CENTRAL INDEX KEY: 0001819663 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 843998117 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-390507 FILM NUMBER: 21678205 BUSINESS ADDRESS: STREET 1: 2030 POWERS FERRY RD., SE, SUITE #212 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 404-816-8240 MAIL ADDRESS: STREET 1: 2030 POWERS FERRY RD., SE, SUITE #212 CITY: ATLANTA STATE: GA ZIP: 30339 D 1 primary_doc.xml X0708 D LIVE 0001819663 VININGS HOLDINGS, INC. 105 BRADFORD ROAD, SUITE 420 WEXFORD PA PENNSYLVANIA 15090 724-934-6467 DELAWARE Naerodynamics, Inc. Health Partnership Inc. Mind 2 Market, Inc., Nelx Marketing, Inc. None Corporation true David Mehalick 105 Bradford Road, Suite 420 Wexford PA PENNSYLVANIA 15090 Executive Officer Director Christine Sheehy 105 Bradford Road, Suite 420 Wexford PA PENNSYLVANIA 15090 Executive Officer Director Daniel Yerace 105 Bradford Road, Suite 420 Wexford PA PENNSYLVANIA 15090 Executive Officer Director Michael Handley 105 Bradford Road, Suite 420 Wexford PA PENNSYLVANIA 15090 Director Pharmaceuticals Decline to Disclose 06b false 2021-02-12 false true true As consideration for the merger of our wholly-owned subsidiary with and into Coeptis Pharmaceuticals, Inc. ("Coeptis"), Coeptis stockholders received one share of our common stock for each share of Coeptis common stock. 0 0 0 0 These shares of common stock were issued as non-cash merger consideration. false 81 0 0 0 false VININGS HOLDINGS, INC. /s/ David Mehalick David Mehalick President 2021-02-25